Evaxion A (EVAX) Non-Current Assets (2019 - 2025)
Evaxion A (EVAX) posted Non-Current Assets of $3.5 million for Q4 2025, down 17.91% on a QoQ basis from $4.3 million in Q2 2025, and down 5.73% year-over-year from $3.7 million in Q4 2024.
Evaxion A (EVAX) Non-Current Assets (2019 - 2025) Analysis & Trends
Evaxion A's Non-Current Assets history runs 7 years deep, the most recent figure standing at $3.5 million for Q4 2025.
- Quarterly Non-Current Assets fell 5.73% year-over-year to $3.5 million in Q4 2025, while the trailing twelve-month figure through Jun 2025 was $4.3 million (down 5.72% YoY) and the FY2025 annual result came in at $3.5 million, down 5.73% from the prior year.
- Non-Current Assets was $3.5 million for Q4 2025 at Evaxion A, down from $4.3 million in the prior quarter.
- Across five years, Non-Current Assets topped out at $7.8 million in Q3 2021 and bottomed at $2.4 million in Q1 2021.
- A 5-year average of $4.8 million and a median of $4.5 million in 2023 frame the typical range for Non-Current Assets.
- Annual changes were most pronounced in 2021 — Non-Current Assets jumped 437.73% — and 2024, when it dropped 18.04%.
- Evaxion A's Non-Current Assets stood at $5.5 million in 2021, then retreated by 7.66% to $5.0 million in 2022, then slipped by 9.94% to $4.5 million in 2023, then fell by 18.04% to $3.7 million in 2024, then decreased by 5.73% to $3.5 million in 2025.
- Business Quant data shows EVAX's Non-Current Assets at $3.5 million in Q4 2025, $4.3 million in Q2 2025, and $3.7 million in Q4 2024.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Non-Current Assets (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 67,072.09 Bn | 67,072.09 Bn | - | 21.65 Mn |
| 2 | Nanobiotix | 1,894.61 Bn | 1,894.55 Bn | - | 5.83 Mn |
| 3 | Akari Therapeutics | 1,014.18 Bn | 1,014.18 Bn | - | 30.30 Mn |
| 4 | BeOne Medicines | 471.64 Bn | 466.85 Bn | 1.35 Bn | 1.95 Bn |
| 5 | Vertex Pharmaceuticals | 121.72 Bn | 114.47 Bn | 2.59 Bn | 14.75 Bn |
| 6 | Regeneron Pharmaceuticals | 68.28 Bn | 59.52 Bn | 3.31 Bn | 22.66 Bn |
| 7 | Belite Bio | 61.40 Bn | 61.40 Bn | - | 289.41 Mn |
| 8 | Argenx Se | 56.94 Bn | 56.94 Bn | 1.18 Bn | - |
| 9 | Revolution Medicines | 37.37 Bn | 37.37 Bn | - | 285.82 Mn |
| 10 | Evaxion A | 1.23 Bn | 1.23 Bn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | 3.51 Mn |
| Jun 30, 2025 | 4.27 Mn |
| Dec 31, 2024 | 3.72 Mn |
| Jun 30, 2024 | 4.53 Mn |
| Dec 31, 2023 | 4.54 Mn |
| Jun 30, 2023 | 5.39 Mn |
| Dec 31, 2022 | 5.04 Mn |
| Jun 30, 2022 | 5.48 Mn |
| Mar 31, 2022 | 5.70 Mn |
| Dec 31, 2021 | 5.46 Mn |
| Sep 30, 2021 | 7.80 Mn |
| Jun 30, 2021 | 4.23 Mn |
| Mar 31, 2021 | 2.43 Mn |
| Dec 31, 2020 | 1.02 Mn |
| Dec 31, 2019 | 126,000.00 |